Identification of New miRNA Biomarkers Associated With HER2-positive Breast Cancers

Oncoscience - United States
doi 10.18632/oncoscience.275
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

A Phenotypic and Mechanistic Perspective on Heterogeneity of HER2-positive Breast Cancers

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2016English

ZW25 Active in HER2-positive Cancers

Cancer Discovery
Oncology
2018English

New Developments in the Treatment of HER2-positive Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2012English

MiR-190b, the Highest Up-Regulated miRNA in ERα-positive Compared to ERα-negative Breast Tumors, a New Biomarker in Breast Cancers?

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Prognostic and Predictive Role of Tumour-Associated Macrophages in HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Intrinsic Molecular Subtypes of Breast Cancers Categorized as HER2-positive Using an Alternative Chromosome 17 Probe Assay

Breast Cancer Research
Cancer ResearchOncology
2018English

Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer

Oncotarget
Oncology
2019English

Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy

Targeted Oncology
Cancer ResearchOncologyPharmacology
2018English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy